Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BridgeBio Pharma
Biotech
BridgeBio cuts gene therapy budget as clinical data disappoint
CEO Neil Kumar said the data “are not yet transformational,” driving BridgeBio to shift its focus to other drug candidates and ways to treat disease.
Nick Paul Taylor
Sep 11, 2024 7:50am
BridgeBio’s offshoot GondolaBio launches with $300M
Aug 21, 2024 11:36am
Moderna, Terremoto, MEI Pharma and more—Chutes & Ladders
Jul 26, 2024 8:30am
BridgeBio posts BioMarin-beating data on dwarfism drug prospect
Jun 4, 2024 7:30am
BridgeBio taps VCs for $200M to fund cancer-focused spinout
May 2, 2024 7:00am
Bayer pays $310M for Europe rights to BridgeBio's Vyndaqel rival
Mar 4, 2024 8:22am
